This company combines impressive quality with a generous valuation: Cabaletta Bio Inc. (CABA)

As of close of business last night, Cabaletta Bio Inc.’s stock clocked out at $11.01, up 7.41% from its previous closing price of $10.25. In other words, the price has increased by $+0.76 from its previous closing price. On the day, 1057331 shares were traded. CABA stock price reached its highest trading level at $11.10 during the session, while it also had its lowest trading level at $10.00.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

To gain a deeper understanding of CABA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.20 and its Current Ratio is at 15.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on August 30, 2022, Downgraded its rating to Equal-Weight and sets its target price to $3 from $15 previously.

On December 08, 2021, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $17.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 19 when Nichtberger Steven bought 8,127 shares for $1.25 per share. The transaction valued at 10,152 led to the insider holds 986,483 shares of the business.

Simon Mark bought 7,000 shares of CABA for $6,835 on Oct 18. The Director now owns 7,000 shares after completing the transaction at $0.98 per share. On Oct 18, another insider, Simon Mark, who serves as the Director of the company, bought 118,000 shares for $0.98 each. As a result, the insider paid 115,286 and bolstered with 136,144 shares of the company.

Stock Price History:

Over the past 52 weeks, CABA has reached a high of $11.91, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is 6.46, while the 200-Day Moving Average is calculated to be 2.60.

Shares Statistics:

It appears that CABA traded 1.06M shares on average per day over the past three months and 774.51k shares per day over the past ten days. A total of 29.01M shares are outstanding, with a floating share count of 27.61M. Insiders hold about 4.10% of the company’s shares, while institutions hold 42.30% stake in the company. Shares short for CABA as of Oct 13, 2022 were 3.56M with a Short Ratio of 3.53M, compared to 4.17M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 12.28% and a Short% of Float of 12.93%.

Earnings Estimates

As of right now, 6 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.48 for the current quarter, with a high estimate of -$0.43 and a low estimate of -$0.56, while EPS last year was -$0.45. The consensus estimate for the next quarter is -$0.48, with high estimates of -$0.38 and low estimates of -$0.67.

Analysts are recommending an EPS of between -$1.27 and -$2.15 for the fiscal current year, implying an average EPS of -$1.77. EPS for the following year is -$1.55, with 7 analysts recommending between -$0.86 and -$2.44.